Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study

Endocrine

Volumn 41, Issue 1, 2012, Pages 103-110

  Daneshpour, Maryam S ^a   Faam, Bita ^a   Mansournia, Mohamad Ali ^b   Hedayati, Mehdi ^a   Halalkhor, Sohrab ^c   Mesbah Namin, Seyed Alireza ^c   Shojaei, Shahla ^a   Zarkesh, Maryam ^a   Azizi, Fereidoun ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AI CIII AIV gene cluster; Coronary artery disease; Haplotype; Lipid and TLGS

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RESTRICTION ENDONUCLEASE; TRIACYLGLYCEROL;

ADULT; AGED; APO AI CIII AIV GENE CLUSTER; APO11Q GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EXON; FEMALE; GENE; GENE AMPLIFICATION; GENE CLUSTER; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC REGULATION; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84862666612     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9526-6     Document Type: Article

References (30)

1. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, E.M. Rubin, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173 (2001) (Pubitemid 32952971)
2. Q.F. Wang, X. Liu, J. O'Connell, Z. Peng, R.M. Krauss, D.L. Rainwater, J.L. VandeBerg, E.M. Rubin, J.F. Cheng, L.A. Pennacchio, Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum. Mol. Genet. 13, 1049-1056 (2004) (Pubitemid 38702191)
3. M. Olivier, X. Wang, R. Cole, B. Gau, J. Kim, E.M. Rubin, L.A. Pennacchio, Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83, 912-923 (2004) (Pubitemid 38469930)
4. J. Gao, Y. Wei, Y. Huang, D. Liu, G. Liu, M. Wu, L. Wu, Q. Zhang, Z. Zhang, R. Zhang, C. Liang, The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. J. Biol. Chem. 280, 12559-12566 (2005)
5. M. Daneshpour, M. Hedayati, P. Eshraghi, F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur. J. Lipid Sci. Technol. (2010 in press)
6. S. Eichenbaum-Voline, M. Olivier, E.L. Jones, R.P. Naoumova, B. Jones, B. Gau, H.N. Patel, M. Seed, D.J. Betteridge, D.J. Galton, E.M. Rubin, J. Scott, C.C. Shoulders, L.A. Pennacchio, Linkage and association between distinct variants of the APOA1/ C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24, 167-174 (2004) (Pubitemid 38082429)
7. R. Mar, P. Pajukanta, H. Allayee, M. Groenendijk, G. Dallinga- Thie, R.M. Krauss, J.S. Sinsheimer, R.M. Cantor, T.W. de Bruin, A.J. Lusis, Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94, 993-999 (2004) (Pubitemid 38490078)
8. M. Groenendijk, R.M. Cantor, T.W. de Bruin, G.M. Dallinga- Thie, The apoAI-CIII-AIV gene cluster. Atherosclerosis 157, 1-11 (2001) (Pubitemid 32539348)
9. D.M. Hallman, S.R. Srinivasan, W. Chen, E. Boerwinkle, G.S. Berenson, Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa heart study. Metabolism 55, 1574-1581 (2006) (Pubitemid 44827122)
10. M.C. Huang, T.N. Wang, Y.L. Liu, T.H. Pa, H.P. Tu, Y.C. Huang, W.T. Chang, Y.C. Ko, Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines. Circ. J. 70, 1030-1036 (2006)
11. J. Song, J.W. Park, H. Park, J.Q. Kim, Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans. Mol. Cells 8, 12-18 (1998) (Pubitemid 128490208)
12. M.S. Daneshpour, M. Hedayati, P. Eshraghi, M. Hooshmand, F. Azizi, Asociation of apolipoprotein E gene polymorphism and lipid level in an Iranian population: Tehran Lipid and Glucose study. Iran. J. Diabet. Lipid 7, 399-405 (2008)
13. M.S. Daneshpour, M. Hedayati, F. Azizi, Association of the TaqI and -629C[A polymorphisms in CETP gene with low level of HDL-C in Tehran. Pajouhesh Q. Res. J. 29, 13-17 (2005)
14. F. Azizi, M. Rahmani, H. Emami, P. Mirmiran, R. Hajipour, M. Madjid, J. Ghanbili, A. Ghanbarian, Y. Mehrabi, N. Saadat, P. Salehi, N. Mortazavi, P. Heydarian, N. Sarbazi, S. Allahverdian, N. Saadati, E. Ainy, S. Moeini, Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 47, 408-426 (2002) (Pubitemid 36285040)
15. F. Azizi, M. Rahmani, H. Emami, M. Madjid, Tehran lipid and glucose study: rationale and design. CVD Prev. 3, 242-247 (2000) (Pubitemid 32423421)
16. F. Azizi, H. Emami, P. Salehi, A. Ghanbarian, P. Mirmiran, M. Mirbolooki, T. Azizi, Cardiovascular risk factors in the elderly: the Tehran lipid and glucose study. J. Cardiovasc. Risk 10, 65-73 (2003)
17. M. Daneshpour, M. Hedayati, P. Eshraghi, and F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur J. Lipid Sci. Technol. (2010)
18. W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972)
19. G.E. Truett, P. Heeger, R.L. Mynatt, A.A. Truett, J.A. Walker, M.L. Warman, Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29, 52-54 (2000) (Pubitemid 30439416)
20. Y. Zou, D. Hu, X. Yang, X. Jia, L. Wang, L. Cui, X. Liu, M. Gao, Y. Wei, Z. Xu, Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Chin. Med. J. (Engl) 116, 665-668 (2003) (Pubitemid 36701841)
21. J. Salas, S. Jansen, J. Lopez-Miranda, J.M. Ordovas, P. Castro, C. Marin, M.A. Ostos, M.D. Bravo, J. Jimenez-Pereperez, A. Blanco, F. Lopez-Segura, F. Perez-Jimenez, The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am. J. Clin. Nutr. 68, 396-401 (1998) (Pubitemid 28355659)
22. T.F. Ejchel, L.M. Araujo, L.R. Ramos, M.S. Cendoroglo, M. de Arruda Cardoso Smith, Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population. Am. J. Med. Genet. B 135B, 65-68 (2005) (Pubitemid 40577857)
23. S. Tas, Strong association of a single nucleotide substitution in the 30-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin. Chem. 35, 256-259 (1989) (Pubitemid 19075602)
24. E.J. Topol, J. Smith, E.F. Plow, Q.K. Wang, Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15(Spec No 2), 117-123 (2006)
25. R. Bahri, E. Esteban, P. Moral, M. Hassine, K. Ben Hamda, H. Chaabani, Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis. 7, 46 (2008)
26. S.Y. Hung, H.H. Liou, L.P. Ger, L.K. Chen, M.C. Liu, H.M. Chung, K.J. Chou, T.H. Chen, C.K. Lin, Y. Yang, Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients. Am. J. Nephrol. 30, 222-231 (2009)
27. T. Nieminen, M. Kahonen, S. Islam, O.T. Raitakari, N. Hutri- Kahonen, J. Marniemi, M. Juonala, R. Rontu, J. Viikari, T. Lehtimaki, Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the cardiovascular risk in young Finns study. Circ. J. 71, 741-745 (2007) (Pubitemid 46683367)
28. P.J. Talmud, E. Hawe, S. Martin, M. Olivier, G.J. Miller, E.M. Rubin, L.A. Pennacchio, S.E. Humphries, Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039-3046 (2002) (Pubitemid 35414817)
29. S.H. Hong, W.H. Park, C.C. Lee, J.H. Song, J.Q. Kim, Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin. Chem. 43, 13-17 (1997) (Pubitemid 27024383)
30. J. Shanker, G. Perumal, V.S. Rao, N.B. Khadrinarasimhiah, S. John, S. Hebbagodi, M. Mukherjee, V.V. Kakkar, Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis. 7, 33 (2008)